Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...

Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...

A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

Genomics company Pacific Biosciences of California (NASDAQ ... giving us a hint as to what we can expect. Illumina posted flat year-on-year revenue, beating analysts’ expectations by 2.1%, and Waters ...

The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...

Illumina (NASDAQ:ILMN – Get Free Report) was downgraded by investment analysts at Barclays from an “equal weight” rating to ...